Outset Medical, Inc. OM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 40.6%+4.7pp | 39.1%+5.2pp | 37.7%+6.7pp | 36.5%+8.2pp | 35.9%+11.3pp | |
| Operating margin | -57.2%+23.4pp | -55.8%+43.9pp | -59.1%+53.2pp | -66.2%+63.1pp | -80.6%+49.9pp | |
| Net margin | -63.7%+35.1pp | -68.3%+44.2pp | -73.1%+49.7pp | -82.1%+54.7pp | -98.7%+36.2pp | |
| EBITDA margin | -53.9%+21.8pp | -52.2%+42.5pp | -55%+52.3pp | -61.8%+62.4pp | -75.7%+50.0pp | |
| Free cash flow margin | -29.1%+54.8pp | -39.4%+63.7pp | -44.9%+65.1pp | -57.3%+62.9pp | -83.9%+24.4pp | |
| Returns | ||||||
| Return on equity | -53.2%+33.4pp | -106.2%+64.8pp | -92.3%+48.7pp | -87.7%+38.8pp | -86.5%+22.5pp | |
| Return on assets | -27.2%+8.0pp | -30.2%+13.2pp | -30.8%+16.1pp | -32.5%+16.6pp | -35.2%+12.5pp | |
| Return on invested capital | -35.9%+4.9pp | -44.8%+32.0pp | -33.7%+25.5pp | -35.4%+26.9pp | -40.8%+19.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×+0.1× | 0.4×+0.1× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 1.3×0.0× | 1.4×0.0× | 1.4×-0.1× | 1.3×-0.2× | 1.3×-0.5× | |
| Liquidity | ||||||
| Current ratio | 6.3×-2.1× | 6.7×+1.0× | 7.1×+0.6× | 7.5×+0.7× | 8.4×+2.0× | |
| Quick ratio | 5×-1.8× | 5.4×+1.0× | 5.8×+0.7× | 6.1×+0.7× | 6.7×+1.4× | |
| Cash ratio | 0.8×-1.4× | 0.9×-1.8× | 1×+0.2× | 1.1×+0.2× | 2.2×+1.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×+0.3× | 0.8×-6.7× | 0.7×-3.5× | 0.6×-2.3× | 0.6×-1.6× | |
| Debt-to-assets | 0.4×+0.1× | 0.4×-0.3× | 0.4×-0.3× | 0.3×-0.3× | 0.3×-0.3× | |
| Interest coverage | -4.9×-0.6× | -4.8×0.0× | -4.3×+1.7× | -4.2×+3.9× | -4.3×+6.1× | |
| Per Share | ||||||
| Book value per share | $6.08-74.8% | $8.35+7.8% | $8.01-41.7% | $8.72-56.0% | $24.14-12.1% | |
| Valuation | ||||||
| Market capitalization | $80.08M-77.6% | $67.35M-76.6% | $250.86M+45.0% | $353.91M-63.3% | $195.76M-64.4% | |
| Enterprise value | $151.13M-63.6% | $133.59M-63.4% | $313.1M-8.4% | $412.79M-63.5% | $218M-69.7% | |
| Price / sales | 0.7×-2.3× | 0.6×-2.0× | 2.1×+0.6× | 3×-5.3× | 1.7×-2.7× | |
| Price / book | 0.7×-1.6× | 0.5×-10.2× | 1.8×-1.9× | 2.3×-11.8× | 1.2×-4.7× | |
| EV / sales | 1.3×-2.2× | 1.1×-2.1× | 2.6×-0.4× | 3.5×-6.2× | 1.9×-3.9× | |
| Free cash flow yield | -42.8%-23.6pp | -70%-29.2pp | -21.5%+51.4pp | -19.3%-4.8pp | -49.4%-24.8pp | |
| Earnings yield | -93.5%-66.0pp | -121.2%-76.7pp | -35%+46.5pp | -27.7%-11.2pp | -58.1%-27.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Outset Medical, Inc.'s profit margins?
- Outset Medical, Inc. (OM) runs a 40.6% gross margin and a -57.2% operating margin, with a -63.7% net margin.
- Where do Outset Medical, Inc.'s ratios come from?
- Every ratio is computed from Outset Medical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
